RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 58 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,416,000 | -78.1% | 318,121 | -53.3% | 0.04% | -78.5% |
| Q4 2019 | $6,467,000 | +12.7% | 680,764 | -6.9% | 0.16% | +30.4% |
| Q3 2019 | $5,737,000 | -47.8% | 730,890 | +4.7% | 0.12% | -54.9% |
| Q2 2019 | $10,986,000 | +14.6% | 698,402 | +31.9% | 0.28% | +1.1% |
| Q1 2019 | $9,586,000 | +89.1% | 529,615 | +68.1% | 0.27% | +33.0% |
| Q4 2018 | $5,068,000 | +12.2% | 315,152 | +67.4% | 0.21% | +50.4% |
| Q3 2018 | $4,518,000 | – | 188,268 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |